Depression is a highly prevalent disorder, and its treatment is far from satisfactory. There is an urgent need to develop a new treatment for depression. Although still at its early stage, transcutaneous auricular vagus nerve stimulation (taVNS) has shown promising potential for treating depression. In this article, we first summarize the results of clinical studies on the treatment effect of taVNS on depression. Then, we re-analyze a previous study to identify the specific symptoms taVNS can relieve as indicated by subscores of the 24-item Hamilton Depression Scale in patients with depression. We found that taVNS can significantly reduce multiple symptoms of depression patients, including anxiety, psychomotor retardation, sleep disturbance, and hopelessness. Next, we pose several hypotheses on the mechanism of taVNS treatment of depression, including directly and indirectly modulating the activity and connectivity of key brain regions involved in depression and mood regulation; inhibiting neuro-inflammatory sensitization; modulating hippocampal neurogenesis; and regulating the microbiome-brain-gut axis. Finally, we outline current challenges and lay out the future directions of taVNS treatment of depression, which include (1) intensively comparing stimulation parameters and "dose effect" (treatment frequency and duration) to maximize the treatment effect of taVNS; (2) exploring the effect of taVNS on disorders comorbid with depression (such as chronic pain disorders, cardiovascular disorder, and autism) to provide new "two-for-one" treatment approaches for patients with these disorders; and (3) applying multiple scale methods to explore the underlying mechanism of taVNS.
Epilepsia. 2012 Jul;53(7):e115-8
[PMID:
22554199]
J Affect Disord. 2016 Nov 15;205:319-326
[PMID:
27559632]
Biol Psychiatry. 2014 Oct 1;76(7):517-26
[PMID:
24629537]
Brain Stimul. 2016 May-Jun;9(3):356-363
[PMID:
27033012]
Am J Psychiatry. 1999 May;156(5):675-82
[PMID:
10327898]
Pain. 2005 Feb;113(3):331-9
[PMID:
15661441]
Neuropsychopharmacology. 2011 Jan;36(1):183-206
[PMID:
20861828]
Psychol Bull. 2014 May;140(3):774-815
[PMID:
24417575]
Front Psychiatry. 2012 Aug 07;3:70
[PMID:
22891061]
Annu Rev Psychol. 2002;53:545-74
[PMID:
11752496]
Eur J Neurol. 2015 Sep;22(9):1260-8
[PMID:
25614179]
Nat Rev Neurosci. 2012 Oct;13(10):701-12
[PMID:
22968153]
Biol Psychiatry. 2000 Oct 15;48(8):830-43
[PMID:
11063978]
J Intern Med. 2017 Jul;282(1):46-63
[PMID:
28421634]
BMC Complement Altern Med. 2012 Dec 14;12:255
[PMID:
23241431]
Nat Rev Immunol. 2009 Jun;9(6):418-28
[PMID:
19461672]
J Audiol Otol. 2015 Dec;19(3):159-67
[PMID:
26771015]
Psychiatry Clin Neurosci. 2009 Dec;63(6):754-61
[PMID:
20021629]
Biol Psychiatry. 2007 Sep 1;62(5):429-37
[PMID:
17210143]
Psychiatry Res. 2011 Mar 31;191(3):153-9
[PMID:
21306877]
J Neural Transm (Vienna). 2013 May;120(5):821-7
[PMID:
23117749]
Neuromodulation. 2017 Apr;20(3):290-300
[PMID:
27898202]
Front Immunol. 2017 Nov 02;8:1452
[PMID:
29163522]
J Cell Physiol. 2016 Sep;231(9):1862-9
[PMID:
26754950]
J Headache Pain. 2015;16:543
[PMID:
26156114]
Neuroimage. 2012 Aug 1;62(1):394-407
[PMID:
22569542]
Curr Opin Neurobiol. 2015 Feb;30:51-8
[PMID:
25240202]
Biomed Tech (Berl). 2008 Jun;53(3):104-11
[PMID:
18601618]
Spine (Phila Pa 1976). 2006 May 1;31(10):1156-62
[PMID:
16648753]
Ann Clin Psychiatry. 2010 Feb;22(1):43-55
[PMID:
20196982]
Nat Neurosci. 2017 Feb;20(2):145-155
[PMID:
28092661]
Trends Neurosci. 2011 Jan;34(1):1-9
[PMID:
21067824]
Brain. 2012 May;135(Pt 5):1508-21
[PMID:
22544901]
Biol Psychiatry. 2016 Feb 15;79(4):266-73
[PMID:
25963932]
Childs Nerv Syst. 2000 Feb;16(2):101-2
[PMID:
10663816]
Front Immunol. 2014 Mar 31;5:136
[PMID:
24744759]
Gen Hosp Psychiatry. 2017 Jan - Feb;44:4-9
[PMID:
28041575]
J Affect Disord. 2013 May;147(1-3):277-87
[PMID:
23270974]
J Med Food. 2014 Dec;17(12):1261-72
[PMID:
25402818]
Zhen Ci Yan Jiu. 2012 Dec;37(6):447-52, 457
[PMID:
23383452]
Curr Pain Headache Rep. 2015 Dec;19(12):54
[PMID:
26493698]
Brain Stimul. 2016 May-Jun;9(3):453-454
[PMID:
26944188]
Gastroenterol Clin North Am. 2017 Mar;46(1):77-89
[PMID:
28164854]
Biol Psychiatry. 2013 Jul 1;74(1):5-6
[PMID:
23787334]
Curr Mol Med. 2016;16(1):33-9
[PMID:
26695696]
Nat Rev Gastroenterol Hepatol. 2015 Jun;12(6):353-62
[PMID:
25963513]
Epilepsy Behav. 2015 Oct;51:18
[PMID:
26262931]
Neuroimage Clin. 2016 Dec 18;14 :105-111
[PMID:
28180068]
Brain Stimul. 2013 Sep;6(5):798-804
[PMID:
23453934]
Mol Psychiatry. 2015 Feb;20(1):32-47
[PMID:
25486982]
Brain Stimul. 2013 Sep;6(5):788-97
[PMID:
23485649]
Adv Exp Med Biol. 2014;817:115-33
[PMID:
24997031]
Chin Med J (Engl). 2014;127(2):300-4
[PMID:
24438620]
Brain Behav Immun. 2005 Nov;19(6):493-9
[PMID:
15922555]
Nature. 2000 May 25;405(6785):458-62
[PMID:
10839541]
Headache. 2016 Jan;56(1):71-8
[PMID:
26364692]
Brain Stimul. 2012 Apr;5(2):163-71
[PMID:
22037127]
Transl Psychiatry. 2015 Nov 17;5:e683
[PMID:
26575224]
Brain Res. 2003 Aug 29;982(2):168-78
[PMID:
12915252]
Neurobiol Aging. 2015 May;36(5):1860-7
[PMID:
25805212]
Arq Neuropsiquiatr. 2014 Jul;72(7):542-7
[PMID:
25054988]
Psychiatry Res. 2006 Mar 31;146(2):179-84
[PMID:
16510266]
BMC Complement Altern Med. 2014 Jun 26;14:203
[PMID:
24968966]
Mol Psychiatry. 2011 Jun;16(6):604-19
[PMID:
21602829]
J Affect Disord. 2016 May;195:172-9
[PMID:
26896810]
Nat Rev Cardiol. 2017 Mar;14 (3):145-155
[PMID:
27853162]
Biol Psychiatry. 2016 Feb 15;79(4):260-1
[PMID:
26796874]
Biol Psychiatry. 2012 Apr 1;71(7):611-7
[PMID:
22177602]
Med J Aust. 2013 Sep 16;199(6 Suppl):S48-51
[PMID:
25370288]
J Chem Neuroanat. 2011 Dec;42(4):288-96
[PMID:
21167932]
Neurology. 2002 Sep 24;59(6 Suppl 4):S3-14
[PMID:
12270962]
Brain Behav Immun. 2017 Nov;66:9-17
[PMID:
28131791]
Brain Stimul. 2015 May-Jun;8(3):624-36
[PMID:
25573069]
Acta Neuropsychiatr. 2017 Mar 8;:1-22
[PMID:
28270247]
Neurosci Biobehav Rev. 2011 Oct;35(9):1929-45
[PMID:
21192971]
J Neurogastroenterol Motil. 2017 Jul 30;23 (3):349-362
[PMID:
28672433]
Gastroenterology. 2017 Mar;152(4):730-744
[PMID:
27988382]
J Neuropsychiatry Clin Neurosci. 1997 Summer;9(3):471-81
[PMID:
9276848]
J Affect Disord. 2012 Dec 15;142(1-3):6-12
[PMID:
22858266]
J Neural Transm (Vienna). 2007;114(11):1485-93
[PMID:
17564758]
Clin Anat. 2002 Jan;15(1):35-7
[PMID:
11835542]
Trends Neurosci. 2003 Jan;26(1):17-22
[PMID:
12495858]
Brain Stimul. 2017 Nov - Dec;10 (6):1042-1044
[PMID:
28803834]
J Clin Neurophysiol. 2010 Apr;27(2):130-8
[PMID:
20505378]
Front Neurosci. 2017 Jan 20;10 :609
[PMID:
28163670]
Pharmacopsychiatry. 2010 Jan;43(1):7-11
[PMID:
20013552]
Curr Opin Neurol. 2008 Aug;21(4):424-30
[PMID:
18607202]
CNS Neurol Disord Drug Targets. 2016;15(4):464-76
[PMID:
26996172]
Front Hum Neurosci. 2013 Sep 24;7:602
[PMID:
24068995]
JAMA Psychiatry. 2013 Apr;70(4):373-82
[PMID:
23389382]